Legal Opinion
Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd.
Court of Appeals for the Federal Circuit
Decided April 14, 2010No. 2010-1001PublishedCited by 17 opinions
1Opinion of the Court
Opinion for the court filed by Circuit Judge RADER. Concurring opinion filed by Circuit Judge CLEVENGER. Dissenting opinion filed by Circuit Judge DYK.
The United States District Court for the Eastern District of Michigan entered an injunction directing Novo Nordisk A/S and Novo Nordisk, Inc. (collectively, “Novo”) to request the U.S. Food and Drug Administration (“FDA”) to replace Novo’s patent use code U-968 listing for Prandin® in the Orange Book with the former U-546 listing. Because Caraco Pharmaceutical Laboratories, Ltd. (“Caraco”) does not have a statutory basis to assert a…
2Cases cited18 opinions
- Barnhart v. ThomasSupreme Court of the United States · 2003
- Buckman Co. v. Plaintiffs' Legal CommitteeSupreme Court of the United States · 2001
- Hughes Aircraft Co. v. JacobsonSupreme Court of the United States · 1999
- Garcia v. United StatesSupreme Court of the United States · 1985
- Estate of Cowart v. Nicklos Drilling Co.Supreme Court of the United States · 1992
13 more not listed; retrieve them via the Exa API.
3Cited by17 opinions
- Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk A/sSupreme Court of the United States · 2012
- ASTRAZENECA LP v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2010
- MORI Associates, Inc. v. United StatesUnited States Court of Federal Claims · 2011
- Novo Nordisk A/S v. Caraco Pharmaceutical Laboratories, Ltd.Court of Appeals for the Federal Circuit · 2013
- BAYER SCHERING PHARMA AG v. Lupin, Ltd.Court of Appeals for the Federal Circuit · 2012
12 more not listed; retrieve them via the Exa API.